August 7, 2025 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 106,322 shares of Neurocrine Biosciences, Inc. at $35.99 per share, a transaction worth $3.83M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.